Oramed Pharmaceuticals (ORMP) Institutional Ownership $2.23 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$2.19 -0.04 (-1.57%) As of 05:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Oramed Pharmaceuticals (NASDAQ:ORMP)CurrentInstitutional OwnershipPercentage12.73%Number ofInstitutional Buyers(last 12 months)12TotalInstitutional Inflows(last 12 months)$6.44MNumber ofInstitutional Sellers(last 12 months)11TotalInstitutional Outflows(last 12 months)$2.02M Get ORMP Insider Trade Alerts Want to know when executives and insiders are buying or selling Oramed Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ORMP Institutional Buying and Selling by Quarter Oramed Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2025 Jane Street Group LLC67,173$144K0.0%+35.3%0.164% 5/13/2025 Rathbones Group PLC236,803$507K0.0%-18.3%0.580% 5/12/2025 Connor Clark & Lunn Investment Management Ltd.87,136$186K0.0%-18.6%0.213% 5/7/2025 N.E.W. Advisory Services LLC18,900$40K0.0%+52.9%0.046% 5/7/2025 BML Capital Management LLC3,020,748$6.46M5.0%+14.3%7.395% 4/30/2025 Peapod Lane Capital LLC252,224$540K0.6%+11.0%0.617% 2/17/2025 Squarepoint Ops LLC54,439$132K0.0%-34.7%0.135% 2/17/2025 Two Sigma Investments LP110,378$267K0.0%-22.1%0.274% 2/17/2025 Two Sigma Advisers LP241,400$584K0.0%-5.6%0.599% 2/17/2025 Millennium Management LLC24,381$59K0.0%-47.8%0.060% Get the Latest News and Ratings for ORMP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025 Bank of America Corp DE167,653$406K0.0%-2.6%0.416% 2/14/2025 Jane Street Group LLC49,663$120K0.0%-14.8%0.123% 2/14/2025 Boothbay Fund Management LLC845,188$2.05M0.1%+2.0%2.097% 2/14/2025 Dimensional Fund Advisors LP118,995$288K0.0%+143.8%0.295% 2/13/2025 Renaissance Technologies LLC151,808$367K0.0%-38.1%0.377% 2/11/2025 LPL Financial LLC17,431$42K0.0%-54.9%0.043% 2/7/2025 BML Capital Management LLC2,643,907$6.40M4.0%+20.9%6.559% 2/4/2025 World Equity Group Inc.20,000$48K0.0%N/A0.050% 1/29/2025 Peapod Lane Capital LLC227,239$550K0.5%N/A0.564% 1/14/2025 Marquette Asset Management LLC33,311$81K0.0%N/A0.083% 11/15/2024 XTX Topco Ltd24,716$60K0.0%+59.7%0.061% 11/15/2024 Murchinson Ltd.1,708,879$4.17M1.1%+0.5%4.239% 11/8/2024 Connor Clark & Lunn Investment Management Ltd.111,519$272K0.0%N/A0.274% 11/5/2024 BML Capital Management LLC2,186,191$5.33M3.1%+62.1%5.362% 8/16/2024 Murchinson Ltd.1,699,990$4.37M0.7%+23.2%4.184% 8/14/2024 Squarepoint Ops LLC81,758$210K0.0%-8.3%0.201% 8/14/2024 Murchinson Ltd.874,992$2.25M0.4%-36.6%2.154% 8/12/2024 XTX Topco Ltd15,474$40K0.0%N/A0.038% 8/9/2024 Renaissance Technologies LLC230,800$593K0.0%+89.0%0.568% 8/9/2024 Dimensional Fund Advisors LP31,470$81K0.0%+52.1%0.077% 5/20/2024 Virtu Financial LLC23,165$68K0.0%N/A0.057% 5/16/2024 Murchinson Ltd.1,379,495$4.03M0.3%+31.4%3.395% 4/24/2024 Assenagon Asset Management S.A.18,659$54K0.0%N/A0.046% 4/23/2024 BML Capital Management LLC844,496$2.47M1.6%-33.1%2.084% 1/30/2024 BML Capital Management LLC1,261,559$2.91M2.2%+61.5%3.127% 11/13/2023 Algert Global LLC14,680$38K0.0%N/A0.036% 11/13/2023 Rathbones Group PLC289,803$756K0.0%N/A0.718% 11/7/2023 Barclays PLC18,406$47K0.0%+39.0%0.046% 11/6/2023 N.E.W. Advisory Services LLC12,960$34K0.0%N/A0.032% 10/23/2023 BML Capital Management LLC781,292$2.04M1.9%-8.1%1.940% Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again.9/21/2023 Barclays PLC13,239$47K0.0%-35.9%0.033% 8/7/2023 Acadian Asset Management LLC31,736$113K0.0%N/A0.079% 7/26/2023 Glass Jacobson Investment Advisors llc12,255$44K0.0%N/A0.031% 7/24/2023 BML Capital Management LLC850,000$3.04M2.7%-37.3%2.123% 5/12/2023 Corsair Capital Management L.P.47,256$103K0.0%N/A0.119% 4/18/2023ETF Managers Group LLC68,940$150K0.0%N/A0.173% 4/14/2023 BML Capital Management LLC1,355,925$2.96M2.6%N/A3.409% 2/14/2023 683 Capital Management LLC20,537$247K0.0%N/A0.052% 2/13/2023 GSA Capital Partners LLP46,039$554K0.1%N/A0.118% 2/9/2023 Landscape Capital Management L.L.C.26,220$315K0.0%N/A0.067% 2/9/2023 Citigroup Inc.65,890$793K0.0%+115.0%0.168% 2/8/2023 Belpointe Asset Management LLC29,900$360K0.0%N/A0.076% 2/8/2023 Russell Investments Group Ltd.56,516$680K0.0%N/A0.144% 2/6/2023 Glass Jacobson Investment Advisors llc9,350$112K0.1%N/A0.024% 2/1/2023Private Portfolio Partners LLC53,600$645K0.2%-20.5%0.137% 2/1/2023 Janney Montgomery Scott LLC12,379$149K0.0%N/A0.032% 1/26/2023 Calamos Advisors LLC14,746$177K0.0%N/A0.038% 1/25/2023 Lindbrook Capital LLC383,351$4.61M0.6%N/A0.980% 1/18/2023 Private Advisor Group LLC11,794$142K0.0%N/A0.030% 11/15/2022ETF Managers Group LLC94,493$612K0.0%+8.2%0.242% 11/14/2022 Cubist Systematic Strategies LLC117,477$761K0.0%+66.1%0.303% 11/14/2022Ergoteles LLC24,149$156K0.0%-89.3%0.062% 11/10/2022 Phoenix Holdings Ltd.13,634$89K0.0%-73.2%0.035% 11/7/2022 Virtu Financial LLC21,526$139K0.0%-19.3%0.055% 11/7/2022Private Portfolio Partners LLC67,400$437K0.1%+24.8%0.174% 11/3/2022 Barclays PLC21,543$140K0.0%+8.7%0.055% 10/31/2022 SG Americas Securities LLC10,370$67K0.0%-77.7%0.027% 10/21/2022Morgan Jess S & Co. Inc.366,401$2.37M2.1%+16.2%0.944% 10/17/2022 Cambridge Investment Research Advisors Inc.14,184$92K0.0%+26.8%0.037% 8/15/2022 Laurion Capital Management LP12,393$57K0.0%N/A0.032% 8/13/2022 Virtu Financial LLC26,661$122K0.0%N/A0.069% 8/11/2022 Bank of Montreal Can249,200$1.35M0.0%N/A0.646% 8/8/2022 Oppenheimer & Co. Inc.50,000$229K0.0%+5.4%0.130% 8/2/2022Private Portfolio Partners LLC54,010$247K0.1%+27.8%0.140% 7/29/2022 SG Americas Securities LLC46,532$213K0.0%N/A0.121% 7/21/2022 Belvedere Trading LLC40,690$343K0.0%N/A0.106% 7/19/2022 Commonwealth Equity Services LLC29,514$135K0.0%+7.1%0.077% 7/18/2022Morgan Jess S & Co. Inc.315,301$1.44M1.5%+8.5%0.818% 7/13/2022 Cambridge Investment Research Advisors Inc.11,184$51K0.0%N/A0.029% 6/30/2022 Amalgamated Bank6,457$56K0.0%N/A0.017% 5/16/2022Morgan Jess S & Co. Inc.290,501$2.51M1.8%+34.9%0.759% 5/12/2022Private Portfolio Partners LLC42,250$365K0.1%N/A0.110% 5/12/2022 Oppenheimer & Co. Inc.47,450$410K0.0%+18.6%0.124% 5/10/2022 Phoenix Holdings Ltd.28,155$244K0.0%-10.1%0.074% 5/9/2022 Rossmore Private Capital40,661$352K0.1%-21.8%0.106% 5/9/2022 Qube Research & Technologies Ltd56,348$487K0.0%-13.0%0.147% 5/5/2022 Russell Investments Group Ltd.43,013$371K0.0%-55.7%0.112% 5/3/2022 Calamos Advisors LLC38,071$330K0.0%-65.9%0.099% 4/25/2022 Assenagon Asset Management S.A.385,413$3.33M0.0%N/A1.007% 4/21/2022 Strs Ohio5,400$46K0.0%-41.9%0.014% Another market crash is coming - here's when (Ad)Magnificent 7 Wipeout: What's Next? The first quarter stock crash and quick recovery has many people confused. And the coming months are critical. You need a big-picture plan... and you need to take specific actions starting TODAY. 50-year Wall Street veteran Marc Chaikin recently published his full big-picture plan, which lays out – based on more than 100 years of data – exactly what you can expect in the markets this year (and in 2026, too).Click here for Marc's critical new update, and the exact date he predicts stocks will crash next.3/3/2022 Walleye Capital LLC36,740$525K0.0%N/A0.096% 2/14/2022 Point72 Hong Kong Ltd2,132$30K0.0%N/A0.006% 2/14/2022ETF Managers Group LLC53,153$729K0.0%+6.5%0.139% 2/14/2022 Rockefeller Capital Management L.P.4,000$57K0.0%N/A0.010% 2/11/2022 Renaissance Technologies LLC203,200$2.90M0.0%N/A0.531% 2/10/2022 Qube Research & Technologies Ltd64,799$925K0.0%N/A0.169% 2/10/2022 OLD Mission Capital LLC38,691$553K0.0%N/A0.101% 2/10/2022 HighTower Advisors LLC14,000$199K0.0%-50.0%0.037% 2/10/2022 Connor Clark & Lunn Investment Management Ltd.50,786$725K0.0%+96.4%0.133% 2/9/2022 BNP Paribas Arbitrage SA20,266$289K0.0%+275.9%0.053% (Data available from 1/1/2016 forward) ORMP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ORMP shares? During the previous two years, 25 institutional investors and hedge funds held shares of Oramed Pharmaceuticals. The most heavily invested institutionals were BML Capital Management LLC ($6.46M), Murchinson Ltd. ($4.17M), Boothbay Fund Management LLC ($2.05M), Two Sigma Advisers LP ($584K), Peapod Lane Capital LLC ($540K), Rathbones Group PLC ($507K), and Bank of America Corp DE ($406K).Learn more on ORMP's institutional investors. What percentage of Oramed Pharmaceuticals stock is owned by institutional investors? 12.73% of Oramed Pharmaceuticals stock is owned by institutional investors. Learn more on ORMP's institutional investor holdings. Which institutional investors have been buying Oramed Pharmaceuticals stock? Of the 19 institutional investors that purchased Oramed Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BML Capital Management LLC ($2.15M), Murchinson Ltd. ($658.88K), Rathbones Group PLC ($289.80K), Peapod Lane Capital LLC ($252.22K), Connor Clark & Lunn Investment Management Ltd. ($111.52K), Renaissance Technologies LLC ($108.70K), and Dimensional Fund Advisors LP ($80.96K). How much institutional buying is happening at Oramed Pharmaceuticals? Institutional investors have bought a total of 3,891,622 shares in the last 24 months. This purchase volume represents approximately $9.63M in transactions. Which Oramed Pharmaceuticals major shareholders have been selling company stock? Of the 13 institutional investors that sold Oramed Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: BML Capital Management LLC ($991.70K), Murchinson Ltd. ($504.50K), Renaissance Technologies LLC ($93.49K), Rathbones Group PLC ($53K), Squarepoint Ops LLC ($36.28K), Two Sigma Investments LP ($31.31K), and Millennium Management LLC ($22.29K). How much institutional selling is happening at Oramed Pharmaceuticals? Institutional investors have sold a total of 1,808,527 shares in the last 24 months. This volume of shares sold represents approximately $5.25M in transactions. Related Companies iTeos Therapeutics Institutional Ownership Revance Therapeutics Institutional Ownership Fulcrum Therapeutics Institutional Ownership Checkpoint Therapeutics Institutional Ownership Vigil Neuroscience Institutional Ownership Rezolute Institutional Ownership Arcturus Therapeutics Institutional Ownership ADC Therapeutics Institutional Ownership Rapport Therapeutics Institutional Ownership Organogenesis Institutional Ownership This page (NASDAQ:ORMP) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy 2026 will be a disaster for many Americans2025 Market Crash The first-quarter stock crash left investors wondering what lies ahead. Today 50-year Wal...Chaikin Analytics | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oramed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oramed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
